Search Results

There are 15163 results for: content related to: Regional cortical grey matter loss in Parkinson's disease without dementia is independent from visual hallucinations

  1. Aripiprazole in Bipolar Disorder

    Bipolar Psychopharmacotherapy: Caring for the Patient, Second Edition

    Alessandra Nivoli, Eduard Vieta, Pages: 245–269, 2011

    Published Online : 13 APR 2011, DOI: 10.1002/9780470975114.ch12

  2. You have free access to this content
    Aripiprazole: A Novel Atypical Antipsychotic Drug With a Uniquely Robust Pharmacology

    CNS Drug Reviews

    Volume 10, Issue 4, December 2004, Pages: 317–336, Marilyn A Davies, Douglas J. Sheffler and Bryan L. Roth

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.2004.tb00030.x

  3. Aripiprazole, a Novel Atypical Antipsychotic Drug

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 24, Issue 2, February 2004, Pages: 212–228, Tami R. Argo, Ryan M. Carnahan and Dr. Paul J. Perry

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.24.2.212.33145

  4. Silent saliva aspiration in Parkinson's disease

    Movement Disorders

    Volume 26, Issue 1, January 2011, Pages: 138–141, Bernardo Rodrigues, Ana Caline Nóbrega, Marília Sampaio, Natalie Argolo and Ailton Melo

    Version of Record online : 16 NOV 2010, DOI: 10.1002/mds.23301

  5. Tardive dyskinesia and other movement disorders secondary to aripiprazole

    Movement Disorders

    Volume 26, Issue 1, January 2011, Pages: 147–152, Maria Sierra Peña, Toby C. Yaltho and Joseph Jankovic

    Version of Record online : 3 SEP 2010, DOI: 10.1002/mds.23402

  6. Apomorphine effect on pain threshold in Parkinson's disease: A clinical and positron emission tomography study

    Movement Disorders

    Volume 26, Issue 1, January 2011, Pages: 153–157, Estelle Dellapina, Angélique Gerdelat-Mas, Fabienne Ory-Magne, Laure Pourcel, Monique Galitzky, Fabienne Calvas, Marion Simonetta-Moreau, Claire Thalamas, Pierre Payoux and Christine Brefel-Courbon

    Version of Record online : 19 OCT 2010, DOI: 10.1002/mds.23406

  7. Lack of a pharmacokinetic drug–drug interaction between lithium and valproate when co-administered with aripiprazole

    Journal of Clinical Pharmacy and Therapeutics

    D. W. Boulton, G. D. Kollia, S. Mallikaarjun and D. M. Kornhauser

    Version of Record online : 14 MAY 2012, DOI: 10.1111/j.1365-2710.2012.1331.x

  8. Lack of a pharmacokinetic drug–drug interaction between lithium and valproate when co-administered with aripiprazole

    Journal of Clinical Pharmacy and Therapeutics

    Volume 37, Issue 5, October 2012, Pages: 565–570, D. W. Boulton, G. D. Kollia, S. Mallikaarjun and D. M. Kornhauser

    Version of Record online : 3 SEP 2012, DOI: 10.1111/j.1365-2710.2012.01331.x

  9. Aripiprazole and its human metabolite OPC14857 reduce, through a presynaptic mechanism, glutamate release in rat prefrontal cortex: Possible relevance to neuroprotective interventions in schizophrenia

    Synapse

    Volume 62, Issue 11, November 2008, Pages: 804–818, Tsung-Tsair Yang and Su-Jane Wang

    Version of Record online : 20 AUG 2008, DOI: 10.1002/syn.20548

  10. Cerebrospinal fluid tau and phosphorylated tau protein are elevated in corticobasal syndrome

    Movement Disorders

    Volume 26, Issue 1, January 2011, Pages: 169–173, M.B. Aerts, R.A.J. Esselink, B.R. Bloem and M.M. Verbeek

    Version of Record online : 10 SEP 2010, DOI: 10.1002/mds.23341

  11. Use of aripiprazole for delirium in the elderly: a short review

    Psychogeriatrics

    Volume 15, Issue 1, March 2015, Pages: 75–84, Eiji Kirino

    Version of Record online : 17 DEC 2014, DOI: 10.1111/psyg.12088

  12. A non-randomized study to investigate the effects of the atypical antipsychotic aripiprazole on the steady-state pharmacokinetics of lamotrigine in patients with bipolar I disorder

    Human Psychopharmacology: Clinical and Experimental

    Volume 24, Issue 2, March 2009, Pages: 145–152, Frank C Schieber, David W Boulton, Alfred H Balch, Robert Croop, Suresh Mallikaarjun, Jeannine Benson and Berit X Carlson

    Version of Record online : 8 JAN 2009, DOI: 10.1002/hup.999

  13. Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392)

    Bipolar Disorders

    Volume 14, Issue 1, February 2012, Pages: 41–53, Berit X Carlson, Terence A Ketter, Wei Sun, Karen Timko, Robert D McQuade, Raymond Sanchez, Estelle Vester-Blokland and Ronald Marcus

    Version of Record online : 13 FEB 2012, DOI: 10.1111/j.1399-5618.2011.00974.x

  14. Use of smell test identification in Parkinson's disease in Mexico: A matched case-control study

    Movement Disorders

    Volume 26, Issue 1, January 2011, Pages: 173–176, Mayela Rodríguez-Violante, Andrew J. Lees, Amin Cervantes-Arriaga, Teresa Corona and Laura Silveira-Moriyama

    Version of Record online : 14 SEP 2010, DOI: 10.1002/mds.23354

  15. Reduced but not oxidized cerebrospinal fluid glutathione levels are lowered in Lewy body diseases

    Movement Disorders

    Volume 26, Issue 1, January 2011, Pages: 176–181, Walter Maetzler, Stefan P. Schmid, Isabel Wurster, Inga Liepelt, Alexandra Gaenslen, Thomas Gasser and Daniela Berg

    Version of Record online : 14 SEP 2010, DOI: 10.1002/mds.23358

  16. Clinical and biochemical characterization of patients with early infantile onset of autosomal recessive GTP cyclohydrolase I deficiency without hyperphenylalaninemia

    Movement Disorders

    Volume 26, Issue 1, January 2011, Pages: 157–161, Thomas Opladen, Georg Hoffmann, Friederike Hörster, Anne-Bärbel Hinz, Katharina Neidhardt, Christine Klein and Nicole Wolf

    Version of Record online : 3 SEP 2010, DOI: 10.1002/mds.23329

  17. You have free access to this content
    Unique Pharmacological Profile of a Novel Antipsychotic Drug, Aripiprazole (OPC-14597)

    CNS Drug Reviews

    Volume 3, Issue 1, March 1997, Pages: 24–33, Masashi Sasa and Taku Amano

    Version of Record online : 29 SEP 2006, DOI: 10.1111/j.1527-3458.1997.tb00314.x

  18. Pharmacokinetics, Tolerability, and Safety of Aripiprazole following Multiple Oral Dosing in Normal Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 44, Issue 2, February 2004, Pages: 179–187, Dr. Suresh Mallikaarjun, Dr. Daniel E. Salazar and Dr. Steven L. Bramer

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270003261901

  19. How well do caregivers detect mild cognitive change in Parkinson's disease?

    Movement Disorders

    Volume 26, Issue 1, January 2011, Pages: 161–164, Sharon L. Naismith, Marilia Pereira, James M. Shine and Simon J.G. Lewis

    Version of Record online : 3 SEP 2010, DOI: 10.1002/mds.23331

  20. Estimation of skeletal muscle energy metabolism in Machado-Joseph disease using 31P-MR spectroscopy

    Movement Disorders

    Volume 26, Issue 1, January 2011, Pages: 165–168, Ichiro Yabe, Khin K. Tha, Takashi Yokota, Kazunori Sato, Hiroyuki Soma, Asako Takei, Satoshi Terae, Koichi Okita and Hidenao Sasaki

    Version of Record online : 3 SEP 2010, DOI: 10.1002/mds.23335